Dadachova Ekaterina, Rivera Johanna, Revskaya Ekaterina, Nakouzi Antonio, Cahill Sean M, Blumenstein Michael, Xiao Hui, Rykunov Dmitry, Casadevall Arturo
Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Nucl Med Biol. 2008 Oct;35(7):755-61. doi: 10.1016/j.nucmedbio.2008.07.001.
There is a lot of interest towards creating therapies and vaccines for Bacillus anthracis, a bacterium which causes anthrax in humans and which spores can be made into potent biological weapons. Systemic injection of lethal factor (LF), edema factor (EF) and protective antigen (PA) in mice produces toxicity, and this protocol is commonly used to investigate the efficacy of specific antibodies in passive protection and vaccine studies. Availability of toxins labeled with imageable radioisotopes would allow to demonstrate their tissue distribution after intravenous injection at toxin concentration that are below pharmacologically significant to avoid masking by toxic effects.
LF, EF and PA were radiolabeled with (188)Re and (99m)Tc, and their performance in vitro was evaluated by macrophages and Chinese hamster ovary cells toxicity assays and by binding to macrophages. Scintigraphic imaging and biodistribution of intravenously (IV) injected (99m)Tc-and (123)I-labeled toxins was performed in BALB/c mice.
Radiolabeled toxins preserved their biological activity. Scatchard-type analysis of the binding of radiolabeled PA to the J774.16 macrophage-like cells revealed 6.6 x 10(4) binding sites per cell with a dissociation constant of 6.7 nM. Comparative scintigraphic imaging of mice injected intravenously with either (99m)Tc-or (123)I-labeled PA, EF and LF toxins demonstrated similar biodistribution patterns with early localization of radioactivity in the liver, spleen, intestines and excretion through kidneys. The finding of renal excretion shortly after IV injection strongly suggests that toxins are rapidly degraded which could contribute to the variability of mouse toxigenic assays. Biodistribution studies confirmed that all three toxins concentrated in the liver and the presence of high levels of radioactivity again implied rapid degradation in vivo.
The availability of (188)Re and (99m)Tc-labeled PA, LF and EF toxins allowed us to confirm the number of PA binding sites per cell, to provide an estimate of the dissociation constant of PA for its receptor and to demonstrate tissue distribution of toxins in mice after intravenous injection.
人们对研发针对炭疽杆菌的治疗方法和疫苗兴趣浓厚。炭疽杆菌可导致人类炭疽病,其孢子可制成强大的生物武器。向小鼠全身注射致死因子(LF)、水肿因子(EF)和保护性抗原(PA)会产生毒性,该方案常用于研究特定抗体在被动保护和疫苗研究中的功效。使用可成像放射性同位素标记毒素,将能够在低于药理学显著浓度的毒素水平下静脉注射后,展示它们的组织分布情况,以避免毒性作用造成的掩盖效应。
用(188)Re和(99m)Tc对LF、EF和PA进行放射性标记,并通过巨噬细胞和中国仓鼠卵巢细胞毒性试验以及与巨噬细胞的结合来评估它们在体外的性能。对BALB/c小鼠进行静脉注射(99m)Tc和(123)I标记毒素后的闪烁成像和生物分布研究。
放射性标记的毒素保留了它们的生物活性。对放射性标记的PA与J774.16巨噬细胞样细胞结合的Scatchard型分析显示,每个细胞有6.6×10(4)个结合位点,解离常数为6.7 nM。对静脉注射(99m)Tc或(123)I标记的PA、EF和LF毒素的小鼠进行比较闪烁成像,结果显示生物分布模式相似,放射性早期定位于肝脏、脾脏、肠道,并通过肾脏排泄。静脉注射后不久发现肾脏排泄,这强烈表明毒素迅速降解,这可能导致小鼠毒性试验的变异性。生物分布研究证实,所有三种毒素都集中在肝脏,高放射性水平的存在再次表明其在体内迅速降解。
(188)Re和(99m)Tc标记的PA、LF和EF毒素的可用性使我们能够确定每个细胞的PA结合位点数量,估计PA与其受体的解离常数,并展示静脉注射后毒素在小鼠体内的组织分布。